These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18070141)

  • 1. Sex differences in response to cyclosporine immunosuppression in experimental kidney transplantation.
    Muller V; Szabo AJ; Erdely A; Tain YL; Baylis C
    Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):574-9. PubMed ID: 18070141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants.
    Redaelli CA; Wagner M; Günter-Duwe D; Tian YH; Stahel PF; Mazzucchelli L; Schmid RA; Schilling MK
    Kidney Int; 2002 Jan; 61(1):288-96. PubMed ID: 11786111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from cyclosporin A to sirolimus retards the progression of chronic allograft nephropathy in the long term in a rat kidney transplantation model.
    He Z; Chen L; Qiu J; Li J; Zhao D; Chen G; Wang C
    J Int Med Res; 2009; 37(5):1396-410. PubMed ID: 19930844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.
    Jolicoeur EM; Qi S; Xu D; Dumont L; Daloze P; Chen H
    Transplantation; 2003 Jan; 75(1):54-9. PubMed ID: 12544871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance induction by intrathymic inoculation prevents chronic renal allograft rejection.
    Blom D; Morrissey N; Mesonero C; Zuo XJ; Jordan S; Fisher T; Bronsther O; Orloff MS
    Transplantation; 1998 Jan; 65(2):272-5. PubMed ID: 9458029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploitation of the continuum between early ischemia/reperfusion injury and host alloresponsiveness: indefinite kidney allograft survival by treatment with a soluble P-selectin ligand and low-dose cyclosporine in combination.
    Kusaka M; Zandi-Nejad K; Kato S; Beato F; Nagano H; Shaw GD; Tilney NL
    Transplantation; 1999 May; 67(9):1255-61. PubMed ID: 10342318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin is less fibrogenic than Cyclosporin A as demonstrated in a rat model of chronic allograft nephropathy.
    Luo L; Sun Z; Luo G
    J Surg Res; 2013 Jan; 179(1):e255-63. PubMed ID: 22480837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model.
    Erickson LM; Pan F; Ebbs A; Kobayashi M; Jiang H
    Transplantation; 2003 Aug; 76(3):582-8. PubMed ID: 12923448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection.
    Vos IH; Joles JA; Schurink M; Weckbecker G; Stojanovic T; Rabelink TJ; Gröne HJ
    Eur J Pharmacol; 2000 Mar; 391(1-2):31-8. PubMed ID: 10720632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
    Azuma H; Chandraker A; Nadeau K; Hancock WW; Carpenter CB; Tilney NL; Sayegh MH
    Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12439-44. PubMed ID: 8901600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model.
    Knoflach A; Azuma H; Magee C; Denton M; Murphy B; Iyengar A; Buelow R; Sayegh MH
    J Am Soc Nephrol; 1999 May; 10(5):1059-66. PubMed ID: 10232693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclosporine A and methotrexate on CD18 expression in recipients of rat cardiac allografts.
    Ciesielski CJ; Mei J; Piccinini LA
    Transpl Immunol; 1998 Jun; 6(2):122-33. PubMed ID: 9777701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection.
    Bédard EL; Jiang J; Parry N; Wang H; Liu W; Garcia B; Kim P; Chakrabarti S; Buelow R; Zhong R
    Transpl Int; 2005 Mar; 18(3):341-9. PubMed ID: 15730496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synergistic effects of C. Sinensis with CsA in preventing allograft rejection.
    Ding C; Tian P; Jia L; Li Y; Ding X; Xiang H; Xue W; Zhao Y
    Front Biosci (Landmark Ed); 2009 Jan; 14(10):3864-71. PubMed ID: 19273316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.